Skip to content

Insider · CIK 0001575843

Amir Nashat

directorowner

Files at CAMP (Camp4 Therapeutics Corp). First filing Oct 15, 2024, latest Sep 11, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 1
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$12M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CAMP: Camp4 Therapeutics Corp

CAMPOct 9, 2026 · close 3.77

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
73Notable
CAMPbuy 7
Camp4 Therapeutics Corp
$2.0M
1,307,189 shares
+82%+106% from low-76% from high
63Notable
CAMPbuy 7
Camp4 Therapeutics Corp
$10.0M
909,090 shares
-+10% from low0% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2025CAMP
Camp4 Therapeutics Corp
POpen-market purchase
Common Stockindirect: See Footnote
+1,221,721$1.53$1.9M2,825,500Sep 11, 2025
Sep 11, 2025CAMP
Camp4 Therapeutics Corp
POpen-market purchase
Common Stockindirect: See Footnote
+85,468$1.53$131k197,661Sep 11, 2025
Jun 25, 2025CAMP
Camp4 Therapeutics Corp
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Common Stockindirect: See Footnote
+1,250,061--1,250,061Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Common Stockindirect: See Footnote
+87,448--87,448Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Common Stockindirect: See Footnote
+353,718--1,603,779Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Common Stockindirect: See Footnote
+24,745--112,193Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
POpen-market purchase
Common Stockindirect: See Footnote
+909,090$11.00$10.0M909,090Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-14,020,475--0Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-980,829--0Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-3,967,234--0Oct 15, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-277,536--0Oct 15, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Amir Nashat: insider trades and track record | InsiderTell